Back to Publications

Countervailing Effects: What the FDA Would Have to Know to Evaluate Tobacco Regulations

Summary

The Family Smoking Prevention and Tobacco Control Act [P.L. 111-31] gives the US Food and Drug Administration (FDA) the authority to regulate tobacco products, including placing restrictions on product composition, sale, and distribution. A complete accounting of the costs and benefits of any tobacco regulation includes harms from possible illicit trade in tobacco products (ITTP): costs of enforcement, violence, incarceration, etc. Indeed, the law instructs the FDA to take into account the “countervailing effects” of regulation on public health, “such as the creation of a significant demand for contraband or other tobacco products that do not meet the requirements.”

Subject
Tobacco
Year
2015
Client/Sponsor
Type
Report

Interested in reading more?

Please fill out the form below to request access to this publication.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.